VANGUARD GROUP INC - SONNET BIOTHERAPEUTC HLDNG I ownership

SONNET BIOTHERAPEUTC HLDNG I's ticker is and the CUSIP is 83548R105. A total of 21 filers reported holding SONNET BIOTHERAPEUTC HLDNG I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SONNET BIOTHERAPEUTC HLDNG I
ValueSharesWeighting
Q2 2022$529,000
-16.3%
1,887,987
+12.3%
0.00%
Q1 2022$632,000
-13.9%
1,681,785
-5.4%
0.00%
Q4 2021$734,000
-31.8%
1,776,953
+0.0%
0.00%
Q3 2021$1,077,000
-2.9%
1,776,753
+153.2%
0.00%
Q2 2021$1,109,000
+262.4%
701,634
+416.0%
0.00%
Q1 2021$306,000
+1.0%
135,9630.0%0.00%
Q4 2020$303,000
+32.9%
135,963
+53.0%
0.00%
Q3 2020$228,00088,8380.00%
Other shareholders
SONNET BIOTHERAPEUTC HLDNG I shareholders Q4 2021
NameSharesValueWeighting ↓
Campion Asset Management 90,612$34,0000.03%
Virtu Financial LLC 112,255$42,0000.00%
Ratio Wealth Group 22,500$8,4600.00%
TWO SIGMA SECURITIES, LLC 118,890$45,0000.00%
Renaissance Technologies 1,801,200$677,0000.00%
Advisory Services Network, LLC 50,525$19,0000.00%
Main Street Financial Solutions, LLC 10,657$4,0000.00%
JANE STREET GROUP, LLC 49,730$19,0000.00%
UBS Group AG 54,955$21,0000.00%
IFP Advisors, Inc 4,000$26,0000.00%
View complete list of SONNET BIOTHERAPEUTC HLDNG I shareholders